Brilinta 60 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F3QWA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,407
Award facts
- Contract value 100% obligated
- $10,406.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Brilinta 60 mg tablets (60-count units) with a ceiling value of $10,406.56. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award carries no set-aside designation, indicating it was competitively awarded through open procurement channels. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical products to support military and veteran healthcare systems. This delivery order for Brilinta, an antiplatelet medication used in cardiovascular treatment, exemplifies the company's role in fulfilling critical pharmaceutical requirements across the Defense Health Agency and other federal healthcare entities. The transaction reflects AmerisourceBergen's established capability to meet federal medical supply demands through its expansive IDC vehicle, which enables flexible sourcing of brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies on a global scale.
Quick answers
Who was awarded contract SPE2DR26F3QWA?
SPE2DR26F3QWA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F3QWA worth?
The government has obligated $10,407 on SPE2DR26F3QWA.
Is contract SPE2DR26F3QWA an order under another contract?
Yes. SPE2DR26F3QWA is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3QWA competed?
The extent of competition for SPE2DR26F3QWA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award